Ireland's most popular source of accurate and reliable medicines information
Search 2614 medicines for SPCs, PILs and Educational Materials
COVID-19 Vaccine Information
Latest medicine updates
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion GlaxoSmithKline (Ireland) Ltd
Updated - Instanyl 50, 100 and 200 mcg nasal spray, solution in single-dose container Takeda Products Ireland Ltd
Updated - Vaxzevria suspension for injection AstraZeneca Pharmaceuticals (Ireland) DAC
Updated - Jyseleca 100 mg and 200 mg film-coated tablets Gilead Sciences Ltd
Updated - Remicade Powder for Solution for Infusion MSD Ireland (Human Health) Limited
Updated - Priligy 30 mg and 60 mg film-coated tablets A. Menarini Pharmaceuticals Ireland Ltd
Updated - Juluca 50 mg/25 mg film-coated tablets ViiV Healthcare UK Ltd
Updated
About Medicines.ie
Medicines.ie contains accurate, up to date, regulator approved information on medicines available in Ireland. The site is designed to be a comprehensive and easily searchable source of medicines information in Ireland.
It is widely regarded as an invaluable reference source by healthcare professionals, the National Medicines Information Center and the Department of Health.
The information for each product comes in the form of a Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflet (PIL) or Package Leaflet (PL), where relevant. These documents are approved by the medicines’ regulator (HPRA or EMA) as part of the process of authorising a medicine for sale or supply in Ireland.
Medicines.ie is continuously updated by pharmaceutical companies when new medicines are launched or the information for an existing medicine changes.
Using Medicines.ie
For information on types of documents on www.medicines.ie, please see below.
Summary of Product Characteristics
Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SPC.
Patient Information Leaflet
A PIL is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the SPC.
Educational Materials
EDMs are additional risk minimisation measures that are intended to promote the safe and effective use of the medicine. Educational materials focus on one or more specific safety concerns related to use of the medicine.
XPIL
Some pharmaceutical companies have chosen to display PIL in a HTML text only “Print View” version, called an XPIL, as well as in PDF format. The XPIL is designed for people who are blind or partially-sighted.